Catalog No | Chemical Name | CAS Number | Purity | Chemical Structure |
---|---|---|---|---|
1811211 | Anlotinib HCl ( AL-3818 ) | 1360460-82-7 | ≧98.0% | ![]() |
Anlotinib is a novel oral tyrosine kinase inhibitor (TKI) targeting c-kit, platelet-d | ||||
2091204 | 5-hydroxy-2,4-dimethylpyrimidine | 412003-95-3 | ≧96.0% | ![]() |
2,4-dimethylpyrimidin-5-ol is a key intermidiate ofLemborexant. Kg scale may be provi | ||||
20103004 | 2,6-difluoro-3,5-dimethoxybenzeneamine | 651734-54-2 | ≧98.0% | ![]() |
2,6-difluoro-3,5-dimethoxybenzeneamine is a key intermeidate ofPemigatinib.1Kg~10Kg s | ||||
20296 | Ecopipam hydrochloride ( SCH-39166 ) | 190133-94-9 | ≧98.0% | ![]() |
Ecopipam HCl is a Selective Dopamine Receptor D1/D5 Antagonist used in the treatment | ||||
21253 | indole-4-boronic acid pinacol ester | 388116-27-6 | ≧95.0% | ![]() |
indole-4-boronic acid pinacol ester, CAS 388116-27-6, is an important intermeidate. | ||||
21254 | 4-(4,4,5,5-TETRAMETHYL-1,3,2-DIOXABOROLAN-2-YL)-1-(TRIISOPROPYLSILYL)-1H-INDOLE | 690632-17-8 | 98% Min. | ![]() |
184163 | 2-amino-3-methoxy-4-(3-morpholin-4-ylpropoxy)benzonitrile | 1032570-98-1 | >96% | ![]() |
2-amino-3-methoxy-4-(3-morpholin-4-ylpropoxy)benzonitrile is a drug intermediate. | ||||
20103005 | 4-chloro-1H-pyrrolo[2,3-b]pyridine-5-carbaldehyde | 958230-19-8 | ≥97% | ![]() |
208191 | OATD-01 | 2088453-21-6 | ≧98.0% | ![]() |
OATD-01,Bulk in stock,contact us by email for the Bulk quotation.OATD-01 is a pot | ||||
191123 | Tafenoquine succinate | 106635-81-8 | >98% | ![]() |
Tafenoquine is being investigated as a potential treatment for malaria, as well as fo | ||||
19381 | Abrocitinib | 1622902-68-4 | >98% | ![]() |
Abrocitinib, Bulk in stock, contact us by email for the quotation. Kg scale intermedi | ||||
51703 | Luminespib ( NVP-AUY922 ; VER-52296 ) | 747412-49-3 | 98% | ![]() |
NVP-AUY922 is an experimental drug candidate for the treatment of cancer. It was disc |
Overnight Delivery
Fast & Safe Delivery Worldwide
Safety and Security
Intimate Service
Copyright 2015-2022 武汉永璨生物科技有限公司 版权所有 | 鄂ICP备17005301号-1